PACT’s 2021 Technology Emerging Company Is Greenphire!
Philadelphia, PA – Greenphire, the industry’s leading global financial lifecycle management provider for clinical trials, is proud to announce it has been awarded the Philadelphia Alliance for Capital and Technology (PACT) 2021 Enterprise Award for Technology Emerging Company.
The finalists, including Infinite Blue and IntegriChain, were chosen from a respected list of technology leaders in the region. All finalists demonstrated product or service innovation and achievement of company milestones. The companies have strong leadership that implemented strategies to accelerate growth and success.
“On behalf of the Greenphire team, we are honored to win the PACT Technology Emerging Company Award,” stated CEO Jim Murphy. “Greenphire’s technology solutions help to bring transparency and efficiency to the clinical trial process; never were these attributes as crucial as in 2020 amidst the COVID-19 pandemic. To win this award this year, reaffirms our value proposition to the research institutions that we serve, helping them get treatments to market as soon as possible. We look forward to growing both our employee base and introducing new product innovations to further transform the industry, right here in the Philadelphia area, for years to come.”
The Enterprise Awards, presented by PACT in partnership with Eisner Amper and Fox Rothschild, recognize and honor leadership and outstanding achievement in investment and in the technology, health, and science industries throughout the region. The Enterprise Awards remain the region’s most prestigious business honors for technology and life sciences companies, leaders, and entrepreneurs. Attracting hundreds of prominent business leaders, the Enterprise Awards’ virtual gala celebrates achievement, innovation, and success in the Greater Philadelphia region.
Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s EnvisiX™, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.
About Philadelphia Alliance for Capital and Technologies (PACT)
PACT’s vision is to be the go-to resource for fast-growing companies and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region. Please visit www.PhiladelphiaPACT.com for more information.